相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation
Aleksandra Czumaj et al.
ANTICANCER RESEARCH (2019)
FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells
Mingjing Shen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Alejandro Schcolnik-Cabrera et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers
Sean P. Pitroda et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting Tumor Metabolism: A New Challenge to improve immunotherapy
Soumaya Kouidhi et al.
FRONTIERS IN IMMUNOLOGY (2018)
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma
Dagmar Kollmann et al.
ONCOIMMUNOLOGY (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target
Douglas Buckley et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
Ornella Franzese et al.
ONCOTARGET (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment
Kathrin Renner et al.
FRONTIERS IN IMMUNOLOGY (2017)
FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
Timothy S. Heuer et al.
EBIOMEDICINE (2017)
Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme
Brittany A. Goods et al.
PLOS ONE (2017)
Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia
Hanna A. Knaus et al.
CURRENT DRUG TARGETS (2017)
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer
Kristin J. Lastwika et al.
CANCER RESEARCH (2016)
Crystal Structure and Substrate Specificity of Human Thioesterase 2: INSIGHTS INTO THE MOLECULAR BASIS FOR THE MODULATION OF FATTY ACID SYNTHASE
Melissa K. Ritchie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
Ramasamy Paulmurugan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark et al.
CANCER RESEARCH (2016)
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
Lei Li et al.
JOURNAL OF HEPATOLOGY (2016)
Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway
Haiyu Wang et al.
CANCER MEDICINE (2016)
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
Lauren Van der Kraak et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells
Fei Yan et al.
PLOS ONE (2016)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng et al.
CANCER RESEARCH (2015)
Molecular Pathways: Fatty Acid Synthase
Suzanne F. Jones et al.
CLINICAL CANCER RESEARCH (2015)
Influence of fatty acid synthase inhibitor orlistat on the DNA repair enzyme O6-methylguanine-DNA methyltransferase in human normal or malignant cells in vitro
Giorgia Cioccoloni et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
Dirk O. Bauerschlag et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids
Diana Cervantes-Madrid et al.
ONCOLOGY REPORTS (2015)
Signal Transduction in Cancer
Richard Sever et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
Yunlang Cai et al.
MEDICAL ONCOLOGY (2015)
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
d Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity
Kattryn E. Hopperton et al.
EXPERIMENTAL CELL RESEARCH (2014)
Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis
Susanne Grube et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas
Michelle Agostini et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The fatty acid synthase inhibitor triclosan: repurposing an antimicrobial agent for targeting prostate cancer
Martin C. Sadowski et al.
ONCOTARGET (2014)
Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
Madhuri Sankaranarayanapillai et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
F. Seguin et al.
BRITISH JOURNAL OF CANCER (2012)
Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration
Zhi Li Liu et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)
Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat
Hui-Qiong Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma
Aadra P. Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
Larissa A. Korde et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
T. Mashima et al.
BRITISH JOURNAL OF CANCER (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
Lynn M. Knowles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: The FRALLE 93 study
Caroline Oudot et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death
Joy L. Little et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
Hailan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells
C. P. Pallasch et al.
LEUKEMIA (2008)
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
Charles W. Pemble et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2
LM Knowles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
JM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
分享论文
